Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
CADL

Updated 10/6/2026, 11:57 AM ET.

CADL

Candel Therapeutics, Inc.

Sale$3,160,783

Tak Paul Peter

Chief Executive Officer, Director

280,245 shat $11.28Filed Sep 11, 6:12 PM ET
Filing
CADL

Candel Therapeutics, Inc.

Sale$84,000

Tyagarajan Seshu

Chief Technology Officer

7,000 shat $12.00Filed Aug 19, 4:30 PM ET
Filing

Read from public SEC filings. Not financial advice.